Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Return on Equity (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Return on Equity for 15 consecutive years, with 0.03% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 7.0% to 0.03% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.03%, a 7.0% decrease, with the full-year FY2024 number at 0.08%, down 6.0% from a year prior.
  • Return on Equity was 0.03% for Q3 2025 at Usana Health Sciences, down from 0.07% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.35% in Q1 2022 to a low of 0.03% in Q3 2025.
  • A 5-year average of 0.17% and a median of 0.14% in 2023 define the central range for Return on Equity.
  • Biggest YoY gain for Return on Equity was 15bps in 2022; the steepest drop was -19bps in 2022.
  • Usana Health Sciences' Return on Equity stood at 0.27% in 2021, then tumbled by -38bps to 0.16% in 2022, then fell by -20bps to 0.13% in 2023, then tumbled by -40bps to 0.08% in 2024, then plummeted by -58bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for USNA's Return on Equity are 0.03% (Q3 2025), 0.07% (Q2 2025), and 0.07% (Q1 2025).